Hypertonic Lactate After Cardiac Arrest
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.
Also called NCT05004610
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 125 participants
- Sponsor
- Registry
-
NCT05004610
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Recruiting
Technical summary
Registry record NCT05004610. Randomized; single masking; primary purpose treatment. Start 2025-02-19 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hypertonic Lactate After Cardiac Arrest
- Acronym
- LATTE
- Condition
- Cardiac Arrest
- Condition
- Ischemia Reperfusion Injury
- Condition
- Anoxic Brain Injury
- Intervention (Drug)
- Sodium Lactate Solution
- Lead sponsor
- Erasme University Hospital
Record details
- Record id
cardio:ct-nct05004610- Content hash
4f288d9253f34c669dfe9403e3878669ac38d6fc6c887b65690eb101405ab1f3